198 related articles for article (PubMed ID: 10630353)
1. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
Ashmore SM; Thomas DG; Darling JL
Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
3. Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes.
Spiegl-Kreinecker S; Buchroithner J; Elbling L; Steiner E; Wurm G; Bodenteich A; Fischer J; Micksche M; Berger W
J Neurooncol; 2002 Mar; 57(1):27-36. PubMed ID: 12125964
[TBL] [Abstract][Full Text] [Related]
4. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance in brain tumors: roles of the blood-brain barrier.
Régina A; Demeule M; Laplante A; Jodoin J; Dagenais C; Berthelet F; Moghrabi A; Béliveau R
Cancer Metastasis Rev; 2001; 20(1-2):13-25. PubMed ID: 11831641
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy.
von Bossanyi P; Diete S; Dietzmann K; Warich-Kirches M; Kirches E
Acta Neuropathol; 1997 Dec; 94(6):605-11. PubMed ID: 9444363
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase.
Rao VV; Anthony DC; Piwnica-Worms D
J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.
Bähr O; Rieger J; Duffner F; Meyermann R; Weller M; Wick W
Brain Pathol; 2003 Oct; 13(4):482-94. PubMed ID: 14655754
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.
Tews DS; Nissen A; Külgen C; Gaumann AK
J Neurooncol; 2000 Dec; 50(3):227-37. PubMed ID: 11263502
[TBL] [Abstract][Full Text] [Related]
10. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
11. Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.
Takamiya Y; Abe Y; Tanaka Y; Tsugu A; Kazuno M; Oshika Y; Maruo K; Ohnishi Y; Sato O; Yamazaki H; Kijima H; Ueyama Y; Tamaoki N; Nakamura M
Br J Cancer; 1997; 76(4):445-50. PubMed ID: 9275020
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
13. Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours.
Beer TW; Rowlands DC; Crocker J
Thorax; 1996 May; 51(5):526-9. PubMed ID: 8711682
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein expression in brain tumors.
Henson JW; Cordon-Cardo C; Posner JB
J Neurooncol; 1992 Sep; 14(1):37-43. PubMed ID: 1361524
[TBL] [Abstract][Full Text] [Related]
15. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
Yu DS; Chang SY; Ma CP
Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
[TBL] [Abstract][Full Text] [Related]
16. Drug-resistance gene expression and progression of astrocytic tumors.
Tanaka S; Kobayashi I; Oka H; Fujii K; Watanabe T; Nagashima T; Hori T
Brain Tumor Pathol; 2001; 18(2):131-7. PubMed ID: 11908869
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of MDR1 P-glycoprotein isoform expression in benign and malignant human prostate cells by isoform-specific monoclonal antibodies.
Kawai K; Sakurai M; Sakai T; Misaki M; Kusano I; Shiraishi T; Yatani R
Cancer Lett; 2000 Mar; 150(2):147-53. PubMed ID: 10704736
[TBL] [Abstract][Full Text] [Related]
20. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
Moran E; Larkin A; Doherty G; Kelehan P; Kennedy S; Clynes M
J Clin Pathol; 1997 Jun; 50(6):465-71. PubMed ID: 9378810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
